The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis-Reference-Cited by-同舟云学术

The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis

Published:2020-02-08 Issue:4 Volume:86 Page:637-645
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Yang Ting¹,Tian Xin¹²,Chen Chao‐Yang¹,Ma Ling‐Yun¹,Zhou Shuang¹,Li Min¹²,Wu Ye³,Zhou Ying¹²^ORCID,Cui Yi‐Min¹²^ORCID

Affiliation:

1. Department of PharmacyPeking University First Hospital Beijing China

2. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical SciencesPeking University Health Science Center Beijing China

3. Department of PediatricsPeking University First Hospital Beijing China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14198

Reference42 articles.

1. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

2. Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System

3. Multiple Sclerosis Coalition. The use of disease modifying therapies in multiple sclerosis: principles and current evidence. National Multiple Sclerosis Society website.http://www.nationalmssociety.org/nationalmssociety/media/msnationalfiles/brochures/dmt_consensus_ms_coalition.pdf. Accessed November 14 2018.

4. Natural history of multiple sclerosis: a unifying concept

5. Defining the clinical course of multiple sclerosis: Results of an international survey

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database;Journal of the Neurological Sciences;2024-08

2. Mapping the Therapeutic Options for Multiple Sclerosis in Brazil: A Comprehensive Analysis;Sclerosis;2024-02-06

3. The Impact of Neuroimmunologic Disease and Developing Nervous System;Pediatric Neurology;2023-11

4. A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study;Revue Neurologique;2023-06

5. Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor;Journal of Immunology Research;2023-04-07